Impact Factor 4.259 | CiteScore 4.30
More on impact ›

Perspective ARTICLE Provisionally accepted The full-text will be published soon. Notify me

Front. Microbiol. | doi: 10.3389/fmicb.2019.02240

Crisis of antimicrobial resistance in China: now and the future

 Junyan Qu1, Yimei Huang2 and  Xiaoju Lyu1*
  • 1West China Hospital, Sichuan University, China
  • 2University of Florida, United States

The crisis of antimicrobial resistance is worsening and has become a major public safety problem in China, seriously endangering human and animal health and ecological environment. Gram-negative bacterial resistance in China is severe: the related pathogens mainly include carbapenem-resistant Acinetobacter, Pseudomonas aeruginosa and Klebsiella pneumoniae. Surging antimicrobial consumption and irrational use of antimicrobials are the main causes of resistance. In China, a variety of strategies are implemented to control the antimicrobial resistance in hospitals, agriculture and environment. However, there is still a long way to go to strengthen the drug resistance surveillance, to reduce the emergence of drug-resistant bacteria, and to find new antimicrobials and therapies for drug-resistant bacteria. Controlling the antimicrobial resistance crisis takes great efforts from the whole society.

Keywords: Crisis, antimicrobial resistance, China, resistance pattern, combating drug resistance

Received: 02 Apr 2019; Accepted: 12 Sep 2019.

Copyright: © 2019 Qu, Huang and Lyu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Dr. Xiaoju Lyu, West China Hospital, Sichuan University, Chengdu, Sichuan Province, China,